Clinical trial
A Study Comparing Irinotecan and Cisplatin (IP) With Etoposide and Cisplatin…
NCT00144989 · Haruhiko Fukuda, Other · Completed
Key facts
| NCT number | NCT00144989 |
|---|---|
| Title | A Study Comparing Irinotecan and Cisplatin (IP) With Etoposide and Cisplatin (EP) Following EP/TRT for LD-SCLC |
| Official title | A Phase III Study Comparing Etoposide and Cisplatin (EP) With Irinotecan and Cisplatin (IP) Following EP Plus Concurrent Accelerated Hyperfractionated Thoracic Irradiation (EP/TRT) for Limited-Stage Small-Cell Lung Cancer : JCOG0202-MF |
| Lead sponsor | Haruhiko Fukuda, Other |
| Collaborators | Ministry of Health, Labour and Welfare, Japan |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Small-Cell-Lung Cancer |
| Intervention type | Drug |
| Interventions | Etoposide and cisplatin after chemoradiotherapy, Irinotecan and cisplatin after chemoradiotherapy |
| Enrollment | 281 |
| Start date | Sep 1, 2002 |
| Primary completion | Sep 1, 2011 |
| Completion | Sep 1, 2011 |
| First posted | Sep 5, 2005 |
| Last update posted | Sep 22, 2016 |
| Countries | Japan |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: